| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | +47.6% |
| Cost of Revenue | $612K | +30.5% |
| Gross Profit | $733K | +65.8% |
| R&D Expense | $3.8M | +9.0% |
| SG&A Expense | $6.8M | -21.0% |
| Operating Income | -$9.8M | +15.3% |
| Interest Expense | $5K | +0.0% |
| Pre-tax Income | -$13.0M | -13.0% |
| Income Tax | $0 |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | -62.5% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $39K | -63.6% |
| Inventory | $1.5M | -41.9% |
| Current Assets | $3.7M | -42.7% |
| Total Assets | $9.9M | -42.4% |
| Current Liabilities | $2.3M | +23.3% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.2M | +26.2% |
| Capital Expenditures | $138K | -55.5% |
| Investing Cash Flow | -$317K | -34.9% |
| Financing Cash Flow | $3.5M | +3424.0% |
| Free Cash Flow | -$5.3M | +27.5% |
| — |
| Net Income | -$13.0M | -13.0% |
| Long-term Debt |
| $137K |
| -2.8% |
| Total Liabilities | $2.6M | +13.9% |
| Stockholders' Equity | $7.3M | -50.9% |